title: [Metastatic involvement of the central nervous system in breast cancer: role of herceptin].
abstract: The metastatic involvement pattern of breast cancer has been changing in recent years and, in this sense, an increase in the incidence of metastatic involvement of the central nervous system (CNS) is being observed. In this situation, the role that the introduction of new therapeutic agents has must still be defined. In this article, we review the possible role played by treatment with Herceptin in the appearance of metastatic involvements of the CNS.
authors.affiliation: Servicio de Oncología Médica, Hospital Universitario de Salamanca, Salamanca. aocana@vhebron.net
authors.forename: A
authors.initials: A
authors.lastname: Ocaña Fernández
authors.forename: M
authors.initials: M
authors.lastname: Navarro Martín
authors.forename: J J
authors.initials: JJ
authors.lastname: Cruz Hernández
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000473:pathology*; D016543:Central Nervous System Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000556:secondary*; D005260:Female; D006801:Humans; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab